Quick Answer
DNA X, Inc. reported Gross Profit of $9.92 million for the year ending 2024.
- DNA X, Inc. showed a decrease of -48.7% in Gross Profit from 2023 to 2024.
- This data is from DNA X, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $5.26 million | Q2 2018: $10.54 million | Q3 2018: $14.06 million | Q1 2019: $9.02 million | Q2 2019: $14.45 million | Q3 2019: $6.88 million | Q1 2020: $2.17 million | Q2 2020: $4.92 million | Q3 2020: $4.40 million | Q1 2021: $2.46 million | Q2 2021: $2.65 million | Q3 2021: $1.78 million | Q1 2022: $1.53 million | Q2 2022: $2.85 million | Q3 2022: $3.32 million | Q1 2023: $4.18 million | Q2 2023: $4.43 million | Q3 2023: $5.60 million | Q1 2024: $2.90 million | Q2 2024: $2.97 million | Q3 2024: $4.23 million | Q1 2025: $8.36 million | Q2 2025: $845.0 thousand | Q3 2025: $1.82 million.
- Over the full 7 years of available data (2018 to 2024), DNA X, Inc.'s Gross Profit has declined by 79.4%.
- Historical annual values: Fiscal year 2024: $9.92 million | Fiscal year 2023: $19.32 million | Fiscal year 2022: $11.62 million | Fiscal year 2021: $6.41 million | Fiscal year 2020: $15.21 million | Fiscal year 2019: $34.51 million | Fiscal year 2018: $48.09 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: